Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-08-27

FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Octreotide Acetate submitted by Hikma Pharmaceuticals USA Inc., updating the product labeling. This action refle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OCTREOTIDE ACETATE (octreotide acetate)

Snippet

SUPPL AP for OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)